Clinical trial
A Randomized Controlled Clinical Trial on the Efficacy and Safety of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-induced Liver Injury
NCT02651350 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Clinical Trial on the Efficacy and Safety of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-induced Liver Injury
- Lead sponsor
- Beijing 302 Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- July 31, 2019
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug-induced liver injury,chronic